Merrimack Pharmaceuticals Inc

Merrimack Pharmaceuticals Inc is an American-based biopharmaceutical company that historically focused on developing innovative cancer treatments. After divesting its key assets, it now mainly operates as a holding company, managing remaining resources and exploring new strategic opportunities. Operating within the biotechnology sector, Merrimack Pharmaceuticals Inc focuses on strategic asset management and identifying new ventures within the life sciences. Its current approach aims to maximise shareholder value through effective deployment of its capital and remaining resources. Monitor the MACK share price by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.